Selective serotonin reuptake inhibitors in treatment of depression

dc.contributor.advisorSzentmiklósi, József András
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.authorGhamary Gilvaei, Aryadokht
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentPórszász, Róbert
dc.contributor.opponentDrimba, László
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.opponentdeptKenézy Kórház Központi Aneszteziológiai és Intenzív Terápiás Osztályhu_HU
dc.date.accessioned2019-01-31T13:42:33Z
dc.date.available2019-01-31T13:42:33Z
dc.date.created2017
dc.description.abstractDepression is a mental disorder, providing a major cause of morbidity worldwide. Several factors contribute to the development of depression. Regarding to the development of depression, many theories exist explaining the mechanisms from different point of views. The three most common treatments for depression are medication, psychotherapy and electroconvulsive therapy. Selective serotonin reuptake inhibitors are the primary medications prescribed, owing to their relatively mild side-effects, and because they are less toxic in overdose than other antidepressants. SSRIs are involved in many drug interactions with potentially serious clinical consequences. The clinical consequences of drug interactions with SSRI are either due to overdosing of the drug combined, or to a serotonin syndrome with neuromuscular and vegetative symptoms.hu_HU
dc.description.correctorLB
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent38hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/263489
dc.language.isoenhu_HU
dc.subjectSelective serotonin reuptake inhibitorshu_HU
dc.subjectSSRIshu_HU
dc.subjectDepressionhu_HU
dc.subject.dspaceDEENK Témalista::Orvostudományhu_HU
dc.titleSelective serotonin reuptake inhibitors in treatment of depressionhu_HU
Fájlok